Hydrogen Peroxide clinical trials
Hydrogen Peroxide is named as an intervention in 4 current clinical trials in our China and India registers. 3 are recruiting patients now. The most common phase is Not applicable. The sponsor with the most trials is First Hospital of China Medical University (3). The most-studied condition is Warts.
Where Hydrogen Peroxide is approved
All regulators →Of the three regulators tracked here, the first to approve Hydrogen Peroxide was Canada, on 3 Dec 2014. It is approved in 2 of the 3 regulators tracked here.
From the regulators' own registers: FDA Drugs@FDA, the EMA medicines list and Health Canada's Notice of Compliance database. Dates are the first listed approval of a product containing only this substance; combination products and nationally authorised EU medicines are not counted.
What health systems spend on Hydrogen Peroxide
All medicines →From NHSBSA Prescription Cost Analysis (Open Government Licence v3.0) and CMS State Drug Utilization Data. Both are gross amounts: neither system publishes its discounts or rebates per drug. Products combining several substances are not counted here.
How Hydrogen Peroxide works
All drug targets →- Common wartPhase 3
- PeriodontitisPhase 3
- Plantar wartPhase 3
- COVID-19Phase 2
- Breast cancerPhase 2
- Cardiovascular disorderPhase 2
- Dermatosis papulosa nigraPhase 2
- Non-melanoma skin carcinomaPhase 2
- Skin cancerPhase 2
- Skin carcinomaPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL71595, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Hydrogen Peroxide
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Hydrogen Peroxide
- ATC code
- A01AB02
- ChEMBL
- CHEMBL71595
- DrugBank
- DB11091
- PubChem CID
- 784
- CAS number
- 7722-84-1
- FDA UNII
- BBX060AN9V
- Wikidata
- Q171877
- Wikipedia
- Hydrogen peroxide
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Hydrogen Peroxide
4 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
Randomized Controlled Clinical Trial of Hyperthermia and Hydrogen Peroxide 3% in the Treatment of Cutaneous Warts
NCT06812065 · ClinicalTrials.gov ↗ · Warts
|
Not applicable | Recruiting | First Hospital of China Medical University | China |
|
Hyperthermia Combined With Hydrogen Peroxide Microneedle Patch for Viral Warts
NCT07534865 · ClinicalTrials.gov ↗ · Warts
|
Not applicable | Recruiting | First Hospital of China Medical University | China |
|
Local Hyperthermia Combined With Topical 3% Hydrogen Peroxide for Refractory Viral Warts
NCT07565350 · ClinicalTrials.gov ↗ · Refactory Warts
|
Not applicable | Recruiting | First Hospital of China Medical University | China |
|
KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer
NCT03946202 · Breast Cancer
|
Phase 2 | Active, closed | Institute of Cancer Research, United Kingdom | India |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Hydrogen Peroxide
3 conditionsSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| First Hospital of China Medical University | 3 |
| Institute of Cancer Research, United Kingdom | 1 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 3 | 3 |
| Clinical trials in India | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Hydrogen Peroxide trials
How many clinical trials are testing Hydrogen Peroxide?
4 current trials in our China and India registers name Hydrogen Peroxide as a drug or biological intervention, as of the registry sync on 9 November 2026. Completed and withdrawn studies are not counted.
Are Hydrogen Peroxide trials recruiting patients?
Yes. 3 of the 4 trials are recruiting: 3 with sites in China. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Hydrogen Peroxide clinical trials?
First Hospital of China Medical University (3) and Institute of Cancer Research, United Kingdom (1). The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Hydrogen Peroxide works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Hydrogen Peroxide works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Hydrogen Peroxide (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 9 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.